Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C ...

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Amwill Health Care Ltd share price was down by -1.93% from the previous closing price of ₹96.05. Who are peers of Amwill ...

(RTTNews) - Biotechnology company Zealand Pharma A/S (ZEAL, ZLPDF.OB) recorded wider net loss for the full year, that reflected lower revenues and higher operating expenses. The company posted net ...

The meeting is expected to cover topics including Medicare drug price negotiations, the role of pharmacy benefit managers, and tariffs on pharmaceutical products, according to an industry source ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a wave of near-copies of the ...

Companies that have grown profits and net profit margins over the past 12 months ...

The tariff threats keep on coming from the US President. On Tuesday, along with cars and semiconductors, he stated that his administration intends to hit pharmaceuticals with 25%+ tariffs. This marks ...